期刊文献+

HE4在慢性阻塞性肺疾病的表达及意义

The expression and meaning of HE4 in chronic obstructive pulmonary disease
原文传递
导出
摘要 目的研究人附睾蛋白4(HE4)在慢性阻塞性肺疾病(COPD)中的表达水平,从而为C O PD寻找新的生物学标志物.方法纳入因肺部疾病接受手术治疗的患者12例,根据获得的肺组织患者的第一秒用力呼气容积/用力肺活量参数分为对照组6例和C O PD组6例,免疫组织化学检测人肺组织内H E4的分布及表达.动物模型中,采用随机数字表法将24只6周C57BL/6雄性小鼠随机分为对照组和COPD组,每组12只.COPD组暴露于3 ppm的臭氧,每周2次,每次3 h;对照组在相同条件下暴露于空气,于1周、3周末次暴露24 h后每组分别处死6只小鼠,采用酶联免疫吸附试验检测臭氧模型小鼠支气管肺泡灌洗液中H E4的表达水平;以1%、2.5%、5%浓度的香烟烟雾提取物预处理人支气管上皮细胞24 h后,采用实时定量逆转录聚合酶链式反应检测HE4 mRNA的表达水平.结果 COPD患者肺组织支气管上皮细胞中H E4表达水平较对照组降低(t=2.267,P<0.05).在1周及3周时,小鼠支气管肺泡灌洗液中HE4表达水平均低于对照组(t=2.423、2.987,P值均<0.05).HE4 mRNA在2.5%、5%香烟烟雾提取物预处理人支气管上皮细胞中表达水平均低于对照组(t=3.895、4.060,P值均<0.05).结论 HE4在COPD支气管上皮细胞中表达水平降低,表明HE4可能参与COPD的发生、发展过程,是COPD潜在的生物学标记物. Objective To study the expression level of human epididymis protein 4 ( HE4) in chronic obstructive pulmonary disease ( COPD) ,so as to find a new biological marker for COPD . Methods According to the obtained parameters of forced expiratory volume in the first second/forced vital capacity ,12 patients who received surgical treatment for lung diseases were included and divided into the control group ( 6 cases) and the COPD group ( 6 cases) .The distribution and expression of HE4 in human lung tissues were detected by immunohistochemistry .In the animal model ,24 male C57BL/6 mice at 6 weeks were randomly divided into control group and COPD group by random number table method ,12 mice in each group .The COPD group was exposed to ozone at 3 ppm twice a week for 3 hours each time ,and the control group was exposed to air under the same conditions .1 week and 3 weeks later ,6 mice were killed 24 hours after the last exposure in each group . Enzyme-linked immunosorbent assay was used to detect HE4 expression in bronchoalveolar lavage fluid in mice .In cell experiments ,human bronchial epithelial cells were pretreated with 1% ,2 .5% ,and 5% concentrations of cigarette smoke extract for 24 hours ,and the expression level of HE4 mRNA was detected by real-time quantitative reverse transcript-polymerase chain reaction .Results There was less HE4 expression in bronchial epithelial cells of COPD group than the control group ( t =2 .267 , P <0 .05) .After 1 and 3 weeks ,the HE4 expression levels in bronchoalveolar lavage fluid of ozone model mice were less than the control group ( t = 2 .423 , 2 .987 ,both P <0 .05) .After pretreatment with 2 .5% ,5% cigarette smoke extract ,the expression levels of HE4 mRNA in human bronchial epithelial cells were less than the control group ( t =3 .895 ,4 .060 ,both P < 0 .05 ) .Conclusions The decreased expression level of HE4 in COPD bronchial epithelial cells indicates that HE4 may be involved in the occurrence and development of COPD and it may be a potential biomarker of COPD .
作者 朱筱慧 贾嫚 许家艳 孟亚奇 乔莹莹 姚欣 Zhu Xiaohui;Jia Man;Xu Jiayan;Meng Yaqi;Qiao Yingying;Yao Xin(Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital ofNanjing Medical University, Nanjing 210029, China;Department of Respiratory Medicine, theThird Affiliated Hospital of Suzhou University, Changzhou 213003, China)
出处 《国际呼吸杂志》 2019年第18期1391-1396,共6页 International Journal of Respiration
关键词 肺疾病 慢性阻塞性 人附睾蛋白4 Pulm onary disease, chronic obstructive Hum an epididymis protein 4
  • 相关文献

参考文献2

二级参考文献29

  • 1Ward PA, Lentsch AB. Endogenous regulation of the acute inflammatory response. Mol Cell Bioehem, 2002, 234-235: 225- 228.
  • 2Higashimoto Y, Elliott WM, Behzad AR, et al. Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. Am J Respir Crit Care Med,2002,166: 200 -207.
  • 3Takizawa H,Tanaka M,Takami K, et al. Increased expression of transforming growth factor-betal in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Cfit Care Med,2001,163:1476- 1483.
  • 4Luisetti M, Piccioni PD, Donnetta AM, et al. Protease- antiprotease imbalance: local evaluation with bronchoalveolar lavage. Respiration, 1992,59 Suppl 1:24-27.
  • 5Eisenberg SP, Hale KK, Heimdal P, et al. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem, 1990,265:7976-7981.
  • 6Tomee JF, Koeter GH, Hiemstra PS, et al. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax, 1998,53 : 114-116.
  • 7Hill AT, Bayley D, Stockley RA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med ,1999 ,160 :893-898.
  • 8Gompertz S, Bayley DL, Hill SL, et al. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax, 2001,56:36-41.
  • 9Kirchhoff C,Habben I, Ivell R, et al. A major human epididymis - specific cDNA encodes a protein with sequence homology to extracel- lular proteinase inhibitors [ J ]. Biol Reprod, 1991,45 ( 2 ) : 350 - 357.
  • 10Clauss A, Lilja H. A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey a- cidic protein[J]. Biochem J,2002,368( Pt1) :233 -242.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部